Nanomedicine in Cancer Targeting and Therapy
Currently, cancer represents a major cause of death in the world, despite all the progress made in developing new therapies [...]
Gespeichert in:
| Veröffentlicht in: | Journal of personalized medicine 2022-08, Vol.12 (8), p.1312 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 8 |
| container_start_page | 1312 |
| container_title | Journal of personalized medicine |
| container_volume | 12 |
| creator | Palamà, Ilaria Elena Leporatti, Stefano |
| description | Currently, cancer represents a major cause of death in the world, despite all the progress made in developing new therapies [...] |
| doi_str_mv | 10.3390/jpm12081312 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9410324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2707837982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c316t-a7d438b33eb8e83f98416ba2c3a377604c2074e5ae0c659e549b7caa380d7ea33</originalsourceid><addsrcrecordid>eNpdkU9LAzEQxYMottSe_AILXgRdTTLZJHsRpPgPil7qOcym03ZLm12zXaHf3i0tUp3LDMyPx3s8xi4FvwPI-f2yXgvJrQAhT1hfcpOlSkl9enT32LBplrwbm0mp-TnrgeYCpBZ9dvuOoVrTtPRloKQMyQiDp5hMMM5pU4Z5gmGaTBYUsd5esLMZrhoaHvaAfT4_TUav6fjj5W30OE49CL1J0UwV2AKACksWZrlVQhcoPSAYo7nynTdFGRL3OsspU3lhPCJYPjWEAAP2sNet26Lz5ilsIq5cHcs1xq2rsHR_P6FcuHn17XIlOEjVCVwfBGL11VKzceuy8bRaYaCqbZw03FgwuZUdevUPXVZtDF28HaWltCozHXWzp3ysmibS7NeM4G5XhDsqAn4A8TR4AA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2706228457</pqid></control><display><type>article</type><title>Nanomedicine in Cancer Targeting and Therapy</title><source>PubMed Central Free</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Palamà, Ilaria Elena ; Leporatti, Stefano</creator><creatorcontrib>Palamà, Ilaria Elena ; Leporatti, Stefano</creatorcontrib><description>Currently, cancer represents a major cause of death in the world, despite all the progress made in developing new therapies [...]</description><identifier>ISSN: 2075-4426</identifier><identifier>EISSN: 2075-4426</identifier><identifier>DOI: 10.3390/jpm12081312</identifier><identifier>PMID: 36013261</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Apoptosis ; Cancer ; Cancer therapies ; Cell death ; Chemoresistance ; Chemotherapy ; Cytotoxicity ; Immune system ; Immunosuppression ; Lymphocytes T ; Medical research ; Nanoparticles ; Nanostructured materials ; Nanotechnology ; Patients ; PD-1 protein ; Precision medicine ; Radiation therapy ; Toll-like receptors</subject><ispartof>Journal of personalized medicine, 2022-08, Vol.12 (8), p.1312</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c316t-a7d438b33eb8e83f98416ba2c3a377604c2074e5ae0c659e549b7caa380d7ea33</citedby><cites>FETCH-LOGICAL-c316t-a7d438b33eb8e83f98416ba2c3a377604c2074e5ae0c659e549b7caa380d7ea33</cites><orcidid>0000-0001-5912-7565 ; 0000-0003-4420-0680</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410324/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410324/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Palamà, Ilaria Elena</creatorcontrib><creatorcontrib>Leporatti, Stefano</creatorcontrib><title>Nanomedicine in Cancer Targeting and Therapy</title><title>Journal of personalized medicine</title><description>Currently, cancer represents a major cause of death in the world, despite all the progress made in developing new therapies [...]</description><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell death</subject><subject>Chemoresistance</subject><subject>Chemotherapy</subject><subject>Cytotoxicity</subject><subject>Immune system</subject><subject>Immunosuppression</subject><subject>Lymphocytes T</subject><subject>Medical research</subject><subject>Nanoparticles</subject><subject>Nanostructured materials</subject><subject>Nanotechnology</subject><subject>Patients</subject><subject>PD-1 protein</subject><subject>Precision medicine</subject><subject>Radiation therapy</subject><subject>Toll-like receptors</subject><issn>2075-4426</issn><issn>2075-4426</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkU9LAzEQxYMottSe_AILXgRdTTLZJHsRpPgPil7qOcym03ZLm12zXaHf3i0tUp3LDMyPx3s8xi4FvwPI-f2yXgvJrQAhT1hfcpOlSkl9enT32LBplrwbm0mp-TnrgeYCpBZ9dvuOoVrTtPRloKQMyQiDp5hMMM5pU4Z5gmGaTBYUsd5esLMZrhoaHvaAfT4_TUav6fjj5W30OE49CL1J0UwV2AKACksWZrlVQhcoPSAYo7nynTdFGRL3OsspU3lhPCJYPjWEAAP2sNet26Lz5ilsIq5cHcs1xq2rsHR_P6FcuHn17XIlOEjVCVwfBGL11VKzceuy8bRaYaCqbZw03FgwuZUdevUPXVZtDF28HaWltCozHXWzp3ysmibS7NeM4G5XhDsqAn4A8TR4AA</recordid><startdate>20220813</startdate><enddate>20220813</enddate><creator>Palamà, Ilaria Elena</creator><creator>Leporatti, Stefano</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5912-7565</orcidid><orcidid>https://orcid.org/0000-0003-4420-0680</orcidid></search><sort><creationdate>20220813</creationdate><title>Nanomedicine in Cancer Targeting and Therapy</title><author>Palamà, Ilaria Elena ; Leporatti, Stefano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c316t-a7d438b33eb8e83f98416ba2c3a377604c2074e5ae0c659e549b7caa380d7ea33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell death</topic><topic>Chemoresistance</topic><topic>Chemotherapy</topic><topic>Cytotoxicity</topic><topic>Immune system</topic><topic>Immunosuppression</topic><topic>Lymphocytes T</topic><topic>Medical research</topic><topic>Nanoparticles</topic><topic>Nanostructured materials</topic><topic>Nanotechnology</topic><topic>Patients</topic><topic>PD-1 protein</topic><topic>Precision medicine</topic><topic>Radiation therapy</topic><topic>Toll-like receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palamà, Ilaria Elena</creatorcontrib><creatorcontrib>Leporatti, Stefano</creatorcontrib><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of personalized medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palamà, Ilaria Elena</au><au>Leporatti, Stefano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanomedicine in Cancer Targeting and Therapy</atitle><jtitle>Journal of personalized medicine</jtitle><date>2022-08-13</date><risdate>2022</risdate><volume>12</volume><issue>8</issue><spage>1312</spage><pages>1312-</pages><issn>2075-4426</issn><eissn>2075-4426</eissn><abstract>Currently, cancer represents a major cause of death in the world, despite all the progress made in developing new therapies [...]</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>36013261</pmid><doi>10.3390/jpm12081312</doi><orcidid>https://orcid.org/0000-0001-5912-7565</orcidid><orcidid>https://orcid.org/0000-0003-4420-0680</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2075-4426 |
| ispartof | Journal of personalized medicine, 2022-08, Vol.12 (8), p.1312 |
| issn | 2075-4426 2075-4426 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9410324 |
| source | PubMed Central Free; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals |
| subjects | Apoptosis Cancer Cancer therapies Cell death Chemoresistance Chemotherapy Cytotoxicity Immune system Immunosuppression Lymphocytes T Medical research Nanoparticles Nanostructured materials Nanotechnology Patients PD-1 protein Precision medicine Radiation therapy Toll-like receptors |
| title | Nanomedicine in Cancer Targeting and Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A00%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanomedicine%20in%20Cancer%20Targeting%20and%20Therapy&rft.jtitle=Journal%20of%20personalized%20medicine&rft.au=Palam%C3%A0,%20Ilaria%20Elena&rft.date=2022-08-13&rft.volume=12&rft.issue=8&rft.spage=1312&rft.pages=1312-&rft.issn=2075-4426&rft.eissn=2075-4426&rft_id=info:doi/10.3390/jpm12081312&rft_dat=%3Cproquest_pubme%3E2707837982%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2706228457&rft_id=info:pmid/36013261&rfr_iscdi=true |